SYNM (Synemin) Gene

Intermediate Filament Protein Gene

Gene Information Card

Symbol SYNM
Full Name Synemin
Gene Type protein-coding
Chromosomal Location 15q26.3
NCBI Gene ID 23336 ncbi.nlm.nih.gov/gene/23336
Ensembl ID ENSG00000137809
UniProt ID O15061
OMIM ID 606087
HGNC ID 11466
Aliases DMN, synemin, desmuslin

Description

The SYNM gene encodes synemin, a large intermediate filament protein that is a component of the cytoskeleton. Synemin is expressed primarily in muscle tissues (skeletal, cardiac, and smooth muscle) and in certain other cell types. It interacts with other intermediate filament proteins such as desmin and vimentin, and with Z-disc proteins, contributing to the structural integrity and mechanical stability of muscle cells. Synemin also plays roles in cell signaling, adhesion, and migration. Mutations and altered expression of SYNM have been associated with myopathies and various cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Myopathy, myofibrillar, 9 (MFM9) Mutations in SYNM disrupt intermediate filament network and Z-disc integrity, leading to muscle fiber degeneration. OMIM #606087; ClinVar
Breast cancer SYNM overexpression or downregulation may affect cell migration and invasion; altered expression linked to prognosis. COSMIC; PubMed studies
Colorectal cancer SYNM expression changes associated with tumor progression and metastasis. COSMIC; PubMed studies

Expression Profile

Tissue Expression
Tissue nTPM level
Skeletal muscle 57.3 High
Heart muscle 42.1 High
Smooth muscle 28.5 Medium
Brain 1.2 Low
Liver 0.5 Not detected
Cell Line Expression
Cell Line nTPM Notes
A549 (lung) 0.8 Low expression
HeLa (cervical) 1.1 Low expression
MCF7 (breast) 3.2 Medium expression
HepG2 (liver) 0.6 Not detected
SK-MEL-28 (melanoma) 2.5 Medium expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1234C>T (p.Arg412*) Nonsense <0.01% Loss of function; associated with myopathy
c.1567G>A (p.Glu523Lys) Missense <0.01% Unknown; reported in cancer
c.2101_2102insA Frameshift <0.01% Loss of function; reported in myopathy
Mutation functional classification

Loss of Function (LOF)

Nonsense and frameshift mutations in SYNM lead to truncated or absent synemin protein, disrupting the intermediate filament network and causing muscle weakness and degeneration.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported for SYNM.

Dominant Negative (DN)

Missense mutations may exert dominant-negative effects by interfering with filament assembly, but evidence is limited.

Gene Ontology (GO)

• structural molecule activity • intermediate filament cytoskeleton organization
• muscle contraction • cell adhesion
• cell migration

Pathways

Intermediate filament organization
Muscle contraction
Cell adhesion (ECM-receptor interaction)

Protein Summary

Synemin is a 160-180 kDa intermediate filament protein that forms heteropolymers with desmin and vimentin. It contains a central alpha-helical rod domain and non-helical head and tail domains. Synemin localizes to Z-discs in striated muscle and dense bodies in smooth muscle, where it links the contractile apparatus to the cytoskeleton. It also interacts with signaling molecules such as alpha-actinin and vinculin, influencing cell adhesion and migration. Post-translational modifications include phosphorylation, which regulates filament dynamics.

Related Products

Product name Cat.No. Species Gene ID
SYNM Knockout HEK293 Cell Line EDJ-KQ7975 Human 23336 Details Get a Quote
SYNM Knockout A-549 Cell Line EDJ-KQ33675 Human 23336 Details Get a Quote
SYNM Knockout HCT 116 Cell Line EDJ-KQ33676 Human 23336 Details Get a Quote
SYNM Knockout HeLa Cell Line EDJ-KQ33677 Human 23336 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: